| Authors: |
Mariani LH; Renal Division, University of Michigan, Ann Arbor, Michigan. Electronic address: lmariani@umich.edu., Trachtman H; Department of Pediatrics/Nephrology, University of Michigan, Ann Arbor, Michigan. Electronic address: howardtrachtman21@gmail.com., Thompson A; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Gillespie BS; Fortrea, Durham, North Carolina; Kidney Center, University of North Carolina, Chapel Hill, North Carolina., Denburg M; Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Diva U; Travere Therapeutics, San Diego, California., Geetha D; School of Medicine, Johns Hopkins University, Baltimore, Maryland., Greasley PJ; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Hladunewich MA; University of Toronto, Toronto, Ontario., Huizinga RB; Aurinia Pharmaceuticals, Victoria, British Columbia, Canada., Inrig JK; Travere Therapeutics, San Diego, California., Komers R; Travere Therapeutics, San Diego, California., Laurin LP; Division of Nephrology, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada., Little DJ; Clinical Development, Late Cardiovascular, Renal and Metabolism, AstraZeneca, Gaithersburg, Maryland., Nachman PH; University of Minnesota, Minneapolis, Minnesota., Smith KA; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Walsh L; Goldfinch Bio, Boston, Massachusetts., Gibson KL; Kidney Center, University of North Carolina, Chapel Hill, North Carolina. |
